Lake Street analyst Frank Takkinen reiterated a Buy rating on Iradimed (IRMD – Research Report) today and set a price target of $70.00. The ...
Arrowhead (ARWR) announced that the global licensing and collaboration agreement with Sarepta Therapeutics (SRPT) announced on November 26, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback